Department of Cardiology, Asklepios Klinik St. Georg, Lohmuehlenstrasse 5, Hamburg, Germany.
J Am Coll Cardiol. 2012 Nov 6;60(19):1921-9. doi: 10.1016/j.jacc.2012.04.060. Epub 2012 Oct 10.
This study describes the 5-year efficacy of catheter ablation for long-standing persistent atrial fibrillation (LS-AF).
Long-term outcome data after catheter ablation for LS-AF are limited.
Long-term follow-up of 56 months (range 49 to 67 months) was performed in 202 patients (age 61 ± 9 years) who underwent the sequential ablation strategy for symptomatic LS-AF. Initial ablation strategy was circumferential pulmonary vein isolation (PVI). Additional ablation was performed only in acute PVI nonresponder, if direct current cardioversion failed after PVI.
After the first ablation procedure, sinus rhythm was documented in 41 of 202 (20.3%) patients. After multiple procedures, sinus rhythm was maintained in 91 of 202 (45.0%) patients, including 24 patients receiving antiarrhythmic drugs. In 105 patients, PVI was the sole ablative therapy, 49 (46.7%) of those patients remained in sinus rhythm during follow-up. Patients with a total AF duration of <2 years had a significantly higher ablation success rate than patients whose AF duration was >2 years (76.5% vs. 42.2%, respectively; p = 0.033). Persistent AF duration (hazard ratio: 1.09 [95% confidence interval: 1.04 to 1.13]; p < 0.001) independently predicted arrhythmia recurrences, and acute PVI responders had a reduced risk of relapse (hazard ratio: 0.57 [95% confidence interval: 0.41 to 0.78]; p < 0.001) after the first ablation.
During 5-year follow-up, single- and multiple ablation procedure success was 20% and 45%, respectively, for patients with LS-AF. For patients with a total AF duration of <2 years, the outcomes were favorable.
本研究描述了导管消融治疗长期持续性心房颤动(LS-AF)的 5 年疗效。
导管消融治疗 LS-AF 的长期结局数据有限。
对 202 例(年龄 61±9 岁)有症状的 LS-AF 患者进行了长达 56 个月(49 至 67 个月)的长期随访,这些患者采用了序贯消融策略。初始消融策略为环形肺静脉隔离(PVI)。如果 PVI 后直流电复律失败,仅在急性 PVI 无反应者中进行额外消融。
在第一次消融手术后,202 例患者中有 41 例(20.3%)记录到窦性心律。经过多次手术,202 例患者中有 91 例(45.0%)维持窦性心律,其中 24 例服用抗心律失常药物。在 105 例患者中,PVI 是唯一的消融治疗方法,其中 49 例(46.7%)在随访期间保持窦性心律。总房颤持续时间<2 年的患者消融成功率显著高于房颤持续时间>2 年的患者(分别为 76.5%和 42.2%;p=0.033)。持续性房颤持续时间(风险比:1.09[95%置信区间:1.04 至 1.13];p<0.001)独立预测心律失常复发,急性 PVI 反应者在第一次消融后复发风险降低(风险比:0.57[95%置信区间:0.41 至 0.78];p<0.001)。
在 5 年随访期间,LS-AF 患者单次和多次消融的成功率分别为 20%和 45%。对于总房颤持续时间<2 年的患者,结果是有利的。